Table 7.
HMDB compound classification of differential metabolites of plasma between NCG group and CON groupa.
| Super classb | Metabolitec | RT (s)d | m/ze | VIPf | p-valueg | Fold changeh |
|---|---|---|---|---|---|---|
| Alkaloids and derivatives | Cytochalasin B | 278.052 | 480.276 | 2.343 | 0.015 | 0.171 |
| Benzenoids | Hippuric acid | 200.125 | 180.065 | 1.846 | 0.014 | 1.456 |
| 4S,5S-antillatoxin A | 436.075 | 504.343 | 2.310 | 0.001 | 1.390 | |
| 2,5-Dihydroxybenzoate | 184.632 | 153.019 | 2.346 | 0.001 | 2.028 | |
| Salicyluric acid | 165.388 | 194.046 | 2.244 | 0.002 | 2.026 | |
| 3-Hhydroxybenzoate | 155.842 | 137.024 | 2.192 | 0.002 | 1.623 | |
| Catechol | 148.222 | 109.029 | 1.647 | 0.039 | 1.390 | |
| Lipids and lipid-like molecules | PGF1 alpha | 419.822 | 325.273 | 1.784 | 0.017 | 1.416 |
| PC (7:0/O-8:0) | 393.329 | 482.323 | 1.453 | 0.047 | 1.257 | |
| PE (18:0/0:0) | 463.252 | 482.323 | 1.569 | 0.032 | 0.847 | |
| PC (P-17:0/0:0) | 461.479 | 494.359 | 1.893 | 0.030 | 0.841 | |
| LysoPC [22:5(4Z,7Z,10Z,13Z,16Z)] | 416.058 | 570.354 | 1.689 | 0.037 | 0.789 | |
| LysoPE [0:0/22:5(4Z,7Z,10Z,13Z,16Z)] | 410.399 | 528.307 | 2.193 | 0.002 | 0.722 | |
| Epigallocatechin 3-O-caffeate | 309.076 | 469.109 | 1.989 | 0.005 | 0.647 | |
| Glycocholic acid | 309.618 | 466.315 | 1.969 | 0.004 | 0.451 | |
| Glycodeoxycholic acid | 354.305 | 450.320 | 2.085 | 0.002 | 0.443 | |
| Smenospongiarine | 350.745 | 414.299 | 2.100 | 0.036 | 0.432 | |
| Tetranor-PGFM | 224.334 | 329.160 | 1.781 | 0.011 | 1.649 | |
| Dodecanedioic acid | 193.524 | 229.144 | 1.824 | 0.020 | 1.447 | |
| Tetradecanedioic acid | 227.044 | 257.176 | 1.941 | 0.008 | 1.367 | |
| PE [18:1(9Z)/0:0] | 426.305 | 478.293 | 1.730 | 0.025 | 1.196 | |
| Phosphatidylcholine lyso 18:1 | 432.200 | 580.361 | 1.911 | 0.008 | 1.162 | |
| 14-methyl palmitic acid | 518.448 | 269.248 | 1.531 | 0.036 | 0.848 | |
| Stearic acid | 546.263 | 283.264 | 1.892 | 0.005 | 0.804 | |
| Eicosa-5Z,8Z-dienoic acid [20:2, n-12] | 517.388 | 307.264 | 1.957 | 0.004 | 0.803 | |
| Phosphatidylcholine lyso 20:4 | 404.111 | 602.346 | 1.969 | 0.006 | 0.781 | |
| Arachidonic Acid | 463.287 | 303.232 | 1.723 | 0.024 | 0.758 | |
| 16-hydroxy hexadecanoic acid | 348.369 | 271.228 | 1.993 | 0.004 | 0.729 | |
| 7Z, 10Z, 13Z, 16Z, 19Z-docosapentaenoic acid | 476.463 | 329.248 | 1.917 | 0.007 | 0.726 | |
| Stearic acid ethyl ester | 613.921 | 311.295 | 1.824 | 0.011 | 0.717 | |
| cis-9,10-Epoxystearic acid | 361.554 | 297.243 | 2.073 | 0.004 | 0.656 | |
| Docosahexanoic acid | 450.270 | 327.232 | 1.841 | 0.032 | 0.638 | |
| Glycocholate | 261.714 | 464.301 | 1.799 | 0.004 | 0.466 | |
| Tauroursodeoxycholic acid | 292.435 | 498.289 | 2.390 | 0.011 | 0.244 | |
| Taurocholic acid | 266.388 | 514.284 | 2.358 | 0.014 | 0.190 | |
| Organic acids and derivatives | Pyroglutamic acid | 60.847 | 130.050 | 1.676 | 0.043 | 1.943 |
| N, N-Dimethylglycine | 35.107 | 104.070 | 1.836 | 0.020 | 1.451 | |
| L-Ornithine | 27.910 | 133.097 | 1.515 | 0.031 | 0.765 | |
| Sarcosine | 34.145 | 88.040 | 1.876 | 0.010 | 1.136 | |
| (R)-2-Hydroxystearic acid | 415.344 | 299.259 | 1.731 | 0.022 | 0.794 | |
| Organic oxygen compounds | 2,8-Dihydroxyquinoline-beta-D-glucuronide | 188.995 | 338.086 | 1.766 | 0.029 | 1.631 |
| Pantothenic acid | 158.242 | 220.117 | 1.623 | 0.036 | 0.756 |
aCON, CON group, N = 6, basal diet without supplementation of N-carbamylglutamate; NCG, N = 8, treatment that added 20 (g/d·head) N-carbamylglutamate.
Based on the chemical structure of the metabolite in HMDB.
The name of the substance that matches in the secondary mass spectrum.
Retention time.
Mass-to-charge ratio.
ariable Importance in the Projection value from OPLS–DA model.
p-Value: p-value from t-test.
The quantitative ratio of the two experimental substances in the NCG group and the CON group.